Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

The Yale School of Public Health is partnering with Tevogen Bio, a clinical stage biotechnology company, on a major expansion of the school's regulatory sciences program.

14 Jul 2021

New study outlines a means to better estimate COVID-19 occurrence and trends

A new study led by the U.S. Geological Survey outlines a means to better estimate COVID-19 occurrence and trends in populations.

14 Jul 2021

Could corticosteroids increase mortality in COVID-19 patients without high oxygen supplementation?

A new paper focuses on the role of corticosteroids, in particular, as these were widely used among patients on intensive respiratory support (IRS).

14 Jul 2021

COVID-19 vaccine booster strategy against Delta variant evidence of growing inequity, says WHO

Could the COVID-19 vaccine booster dose strategy being planned in wealthyy nations underscore issues of health inequality?

14 Jul 2021

How has extensive media coverage of AstraZeneca COVID-19 vaccine-related fatal events impacted healthcare services in Norway?

Scientists from Sweden and Norway have recently investigated how media reportage on fatal side-effects of the Oxford-AstraZeneca vaccine has impacted the use of healthcare services among newly vaccinated healthcare workers. The findings reveal that the media reporting has caused a sharp increase in primary and specialist healthcare service utilization by healthcare staff.

14 Jul 2021

Is niclosamide a potential SARS-CoV-2 antiviral inhibitor?

Niclosamide is an antihelminthic drug, historically used to treat tapeworm infestations, though has been investigated and repurposed for use against SARS-CoV-2. In a new study recently uploaded to the preprint server bioRxiv* by Garrett et al. (July 12, 2021), the drug demonstrates the ability to reorganize the lipid profile of SARS-CoV-2 infected Vero E6 cells, thereby limiting virus replication.

14 Jul 2021

Red state, blue state, twin outbreak: Behind Wyoming and Colorado’s anomalous covid spikes

Brandon Graves said covid-19 arrived in Wheatland the way new movies do in this High Plains farming town: months after hitting the big cities and without much fanfare.

14 Jul 2021

New study finds an association between alcohol use and higher risk of several cancers

A new study from the World Health Organization's International Agency for Research on Cancer (IARC), published in the journal Lancet Oncology, has found an association between alcohol and a substantially higher risk of several forms of cancer, including breast, colon, and oral cancers.

14 Jul 2021

People with learning disabilities are at higher risk of covid-19 related hospitalizations, deaths

People with learning disabilities with covid-19 are five times more likely to be admitted to hospital and eight times more likely to die compared with the general population of England, finds a study published by The BMJ today.

14 Jul 2021

Study: COVID-19 has not led to a net increase in smoking unlike other natural disasters

Unlike other population-level stressful events such as natural disasters, COVID-19 has not resulted in a net increase in smoking, according to a new study from the International Tobacco Control (ITC) Project, at the University of Waterloo.

14 Jul 2021

SARS-CoV-2 variants show distinct humoral response and transcriptional profiles in hamster model

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel, highly infectious respiratory virus, and the causative agent of coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2, which first originated in Wuhan, in Hubei province of China, is a member of the Coronavirdae family and has a large, non-segmented RNA genome.

14 Jul 2021

Effects of the COVID-19 pandemic on weight and BMI among UK adults

Strict lockdowns have been implemented in many countries since the beginning of 2020 to limit morbidity and mortality due to the COVID-19 pandemic. A COVID-19-related lockdown was first imposed in the UK in March 2020, and restrictions then eased from June and July onwards before implementing harsher restrictions at the beginning of October. Various forms of lockdowns with different timing and duration were enforced across the UK in November and December 2020.

14 Jul 2021

SARS-CoV-2 mutations occur in essentially the same locations, research finds

New research from the University of Nebraska-Lincoln has shown that the mutations arising in the COVID-19-causing SARS-CoV-2 virus seem to run in the family -- or at least the genus of coronaviruses most dangerous to humans.

14 Jul 2021

High individual-level variability in SARS-CoV-2 shedding may explain superspreading

Researchers in the United States have provided a high-resolution description of the viral dynamics involved in acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

14 Jul 2021

Study assesses the prevalence of psychiatric symptoms before and during the COVID-19 pandemic

The COVID-19 pandemic and the situations of stress and sadness associated with it have not significantly increased the prevalence of depression and anxiety among participants in the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil) who live in the city of São Paulo.

13 Jul 2021

Pandemic News and Research

Further Reading

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

New study outlines a means to better estimate COVID-19 occurrence and trends

Could corticosteroids increase mortality in COVID-19 patients without high oxygen supplementation?

COVID-19 vaccine booster strategy against Delta variant evidence of growing inequity, says WHO

How has extensive media coverage of AstraZeneca COVID-19 vaccine-related fatal events impacted healthcare services in Norway?

Is niclosamide a potential SARS-CoV-2 antiviral inhibitor?

Red state, blue state, twin outbreak: Behind Wyoming and Colorado’s anomalous covid spikes

New study finds an association between alcohol use and higher risk of several cancers

People with learning disabilities are at higher risk of covid-19 related hospitalizations, deaths

Study: COVID-19 has not led to a net increase in smoking unlike other natural disasters

SARS-CoV-2 variants show distinct humoral response and transcriptional profiles in hamster model

Effects of the COVID-19 pandemic on weight and BMI among UK adults

SARS-CoV-2 mutations occur in essentially the same locations, research finds

High individual-level variability in SARS-CoV-2 shedding may explain superspreading

Study assesses the prevalence of psychiatric symptoms before and during the COVID-19 pandemic

Study evaluates COVID-19's impact on food-shopping behavior for food-insecure populations

Leading cardiovascular organizations call for global action to improve clinician well-being

Wildtype SARS-CoV-2 more widespread in 10-19-year-olds prior to vaccine availability in the USA

EU travel pass comes under fire for leaving behind Covishield recipients

Scientists identify existing drugs that may inhibit SARS-CoV-2 virus

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News